Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Using a Nanotechnology Structured Water Magnalife® to Achieve Controlled Blood Glucose Level in Type 2 Diabetic Patients.

NCT04082351 is registered in ClinicalTrials.gov with ALI KAMAL M. SAMI as lead sponsor.

NCT NCT04082351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04082351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Using a Nanotechnology Structured Water Magnalife® to Achieve Controlled Blood Glucose Level in Type 2 Diabetic Patients.
Lead sponsor
ALI KAMAL M. SAMI
Phase
Not applicable
Overall status
Completed
Start date
July 3, 2016
Completion date
February 16, 2018
Enrollment
387 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes